Agah Ramtin — SEC insider filings
SEC reporting owner CIK 1862617. 23 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2021-10-04 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 15 legs across 14 filings — 272,165 shares, $217,593 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: purchase of 50,000 shares @ $0.93 ($46,485) in RenovoRx, Inc., filed 2026-11-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RenovoRx, Inc. (RNXT) | Executive Chairman and CMO, Director | 23 | 15 legs · 272,165 sh · $217,593 | — | 15 |
Insider filings — Agah Ramtin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 50,000 @ $0.93 | EDGAR |
| 2026-04-07 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 621,727 (derivative) @ $0 | EDGAR |
| 2026-01-22 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 10,000 @ $1.00 | EDGAR |
| 2026-01-05 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 9,795 @ $0.86 | EDGAR |
| 2026-01-02 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 205 @ $0.83 | EDGAR |
| 2025-12-17 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 12,000 @ $0.85 | EDGAR |
| 2025-12-08 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 10,000 @ $0.96 | EDGAR |
| 2025-11-24 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 10,000 @ $0.80 · Purchase (P): 12,000 @ $0.80 | EDGAR |
| 2025-07-03 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 63,636 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 21,000 @ $1.40 | EDGAR |
| 2025-06-06 | 4 | RenovoRx, Inc. (RNXT) | Gift (G): 400,000 @ $0 | EDGAR |
| 2025-04-17 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 15,000 @ $0.90 | EDGAR |
| 2025-04-16 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 254,542 (derivative) @ $0 | EDGAR |
| 2025-04-14 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 20,000 @ $0.80 | EDGAR |
| 2025-04-10 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 30,000 @ $0.81 | EDGAR |
| 2025-04-09 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 26,000 @ $0.84 | EDGAR |
| 2024-01-30 | 4 | RenovoRx, Inc. (RNXT) | Purchase (P): 40,983 · Purchase (P): 40,983 (derivative) | EDGAR |
| 2024-01-23 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 28,424 (derivative) @ $0 · Grant/award (A): 125,132 (derivative) @ $0 | EDGAR |
| 2023-03-29 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2022-06-17 | 4 | RenovoRx, Inc. (RNXT) | Conversion (C): 1,295 · Conversion (C): 1,295 (derivative) @ $0 · Conversion (C): 1,295 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | RenovoRx, Inc. (RNXT) | Gift (G): 975,000 @ $0 · Gift (G): 975,000 @ $0 · Purchase (P): 5,182 @ $1.93 | EDGAR |
| 2022-03-14 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 21,398 (derivative) @ $0 | EDGAR |
| 2021-10-04 | 4 | RenovoRx, Inc. (RNXT) | Grant/award (A): 52,203 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1862617 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs